share_log

8-K: Ainos Reports First Quarter 2024 Financial Results Strategic focus on VELDONA and AI-powered point-of-care testing continues during 2024 US$9M growth capital secured in May strengthens financial position for executing growth strategy

8-K: Ainos Reports First Quarter 2024 Financial Results Strategic focus on VELDONA and AI-powered point-of-care testing continues during 2024 US$9M growth capital secured in May strengthens financial position for executing growth strategy

8-K:Ainos公布2024年第一季度财务业绩2024年继续将战略重点放在VELDONA和人工智能驱动的即时医疗测试上。5月获得的900万美元增长资本巩固了执行增长战略的财务状况
美股SEC公告 ·  2024/05/13 16:15
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息